Posted On: 03/09/2014 10:40:01 PM
Post# of 4
Latest Gbc Biotech (GAGXF) Headlines
Global Sepsis Clinical Trials Review Report - H2 2013 Edition
M2 - Fri Nov 22, 8:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/zlhdr5/sepsis_global) has announced the addition of the "Sepsis Global Clinical Trials Review, H2, 2013" report to their offering. Sepsis Global Clinical Trials Review, H2, 2013" provides data on the Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sepsis. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Sepsis Therapeutics Clinical Trials - Clinical Trial Profiles - Eli Lilly and Company - AstraZeneca PLC - Biosynexus Incorporated - Pfizer Inc. - GlaxoSmithKline plc - Toyama Chemical Co., Ltd. - Am-Pharma B.V. - Takeda Pharmaceutical Company Limited - Venus Remedies Limited - Bayer AG - UMC Utrecht Holding BV - Eisai Inc. - Bharat Serums And Vaccines Limited - Sirtris Pharmaceuticals, Inc. - Altor BioScience Corporation - ICOS Corporation - Agennix AG - Brahms AG - MicroPhage Inc. - Teijin Limited For more information visit http://www.researchandmarkets.com/research/zl...sis_global
Agennix AG Schedules Fiscal Year 2012 Reporting Date and Conference Call on March 28
Marketwire - Tue Feb 19, 3:12AM CST
Agennix AG (FRANKFURT: AGX) today announced that the Company will publish its financial results for fiscal year 2012 on Thursday, March 28, 2013 followed by a conference call to discuss the results and to provide a business update.
Global Sepsis Clinical Trials Review Report - H2 2013 Edition
M2 - Fri Nov 22, 8:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/zlhdr5/sepsis_global) has announced the addition of the "Sepsis Global Clinical Trials Review, H2, 2013" report to their offering. Sepsis Global Clinical Trials Review, H2, 2013" provides data on the Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sepsis. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Sepsis Therapeutics Clinical Trials - Clinical Trial Profiles - Eli Lilly and Company - AstraZeneca PLC - Biosynexus Incorporated - Pfizer Inc. - GlaxoSmithKline plc - Toyama Chemical Co., Ltd. - Am-Pharma B.V. - Takeda Pharmaceutical Company Limited - Venus Remedies Limited - Bayer AG - UMC Utrecht Holding BV - Eisai Inc. - Bharat Serums And Vaccines Limited - Sirtris Pharmaceuticals, Inc. - Altor BioScience Corporation - ICOS Corporation - Agennix AG - Brahms AG - MicroPhage Inc. - Teijin Limited For more information visit http://www.researchandmarkets.com/research/zl...sis_global
Agennix AG Schedules Fiscal Year 2012 Reporting Date and Conference Call on March 28
Marketwire - Tue Feb 19, 3:12AM CST
Agennix AG (FRANKFURT: AGX) today announced that the Company will publish its financial results for fiscal year 2012 on Thursday, March 28, 2013 followed by a conference call to discuss the results and to provide a business update.
(0)
(0)
